Hepatitis B core-related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen-negative chronic hepatitis B patients.
Shun KanekoMasayuki KurosakiKento InadaSakura KirinoYuka HayakawaKoji YamashitaLeona OsawaShuhei SekiguchiMayu HiguchiKenta TakauraChiaki MaeyashikiNobuharu TamakiYutaka YasuiJun ItakuraYuka TakahashiKaoru TsuchiyaHiroyuki NakanishiNamiki IzumiPublished in: Journal of gastroenterology and hepatology (2021)
Hepatitis B core-related antigen was useful for understanding disease progression in CHB patients and for stratifying the risk for carcinogenesis in HBeAg-negative patients receiving NA therapy.